Viral Antigens Market Analysis
The global viral antigens market is estimated at US$ 175.9 billion in 2022 and is forecasted to expand at a high-value CAGR of 8.2% to reach a market size of US$ 388.1 billion by the end of 2032.
Viral antigens are gaining attention owing to
advancements in microbiology as well as vaccine development, in which, North
America is the most favorable market for manufacturers of viral antigens.
Download
Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=1305?SP
Key findings of the Viral Antigens market
study:
·
Regional breakdown of the Viral Antigens
market based on predefined taxonomy.
·
Innovative manufacturing processes
implemented by Viral Antigens vendors in detail.
·
Region-wise and country-wise fragmentation of
the Viral Antigens market to grasp the revenue, and growth outlook in these
areas.
·
Changing preferences among consumers across various
regions and countries.
·
Factors (Positive and Negative) impacting the
growth of the global Viral Antigens market.
Competitive Landscape:
Prominent
viral antigen manufacturers are Microbix Biosystems Inc., Bio Rad Laboratories,
Creative Diagnostics, Aalto Bio Reagents, ProSpec-Tany TechnoGene Ltd., The
native antigen company, Meridian bioscience, Inbios, Rekom biotech, and Sekbio.
Technological
improvements in the biopharmaceutical industry are providing
substantial growth prospects for viral antigen suppliers. Additionally,
manufacturers are focusing on new product launches and product development.
Hence, the rise in new product launches and developments, including the
introduction of numerous novel recombinant antigens for the growth of antibody
tests for COVID-19, will hasten the development of the market.
Apart
from organic tactics, key market players are also adopting inorganic growth
strategies for business expansion and the generation of a high-revenue share in
the market.
- In May 2020,
the U.S. FDA issued the EUA to Quidel Corporation for its Sofia 2 SARS
Antigen FIA. It is a new category of test that can quickly detect protein
particles on or within the coronavirus. The test is conducted by taking
samples from the nasal cavity of patients.
- In May 2020, Bio-Rad
Laboratories, a U.S.-based developer of high-quality products for the
clinical diagnostics market, bagged the EUA approval for its SARS-CoV-2
Total Ab test from the U.S. FDA. It is a blood-based test for identifying
the antibodies created by the human body in response to COVID-19.
For In-Depth Competitive
Analysis, Buy now:
https://www.factmr.com/checkout/1305?SP
Segmentation of Viral Antigens Industry Research:
- By Component :
o Influenza
o Coronavirus
o Zika
o Ebola
o Dengue
o Herpes Simplex Virus (HSV)
o Rotavirus
o Epstein-Barr
o Hepatitis A-E
o Parainfluenza
o Measles
o Adenovirus
o Mumps/Parotitis
o Varicella Zoster Virus (VZV)
o Others
- By Detection Technique :
o ELISA
o Immunoassay
o Hemagglutination
o Radioimmunoassay (RIA)
o Immunoperoxidase Staining
o Immunofluorescence
o Electron Microscopy
o Others
- By End User :
o Hospitals
o Clinics
o Laboratories
o Diagnostic Centers
o Blood Banks
o Research Institutes
- By Region :
o North America
o Latin America
o Europe
o East Asia
o South Asia & ASEAN
o Oceania
o MEA
Queries addressed in the Viral Antigens
market report:
·
Why are the Viral Antigens market players
targeting region for increased product sales?
·
What patented technologies are the players
utilizing in the global Viral Antigens market?
·
Which regions are displaying the fastest
growth in the Viral Antigens market?
·
What are the underlying micro- macroeconomic
factors affecting the global Viral Antigens market?
Contact:
US Sales
Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Comments
Post a Comment